Long
ALPN and VRTX may merge surge of bullish momentum LONG
Alpine is a biotech stock that had an earnings report beating estimates two weeks ago. It
is now reaching for all-time highs. That said, it is burning cash just slowing down the burn.
Both revenue and earnings showed remarkable improvement as compared with the previous
quarter. The bullish momentum of price and volume is obvious on the weeky chart with
the print of a massive bullish engulfing candle. Another earnings report is
due in 4 weeks. In the meanwhile, the news catalyst is VRTX and ALPN may be merging.
https://tradingview.sweetlogin.com/news/DJN_DN20240411006318:0/
I will take a risky long trade here with a stop loss at 50 and a profit first target
of 80 and the second at 90.
is now reaching for all-time highs. That said, it is burning cash just slowing down the burn.
Both revenue and earnings showed remarkable improvement as compared with the previous
quarter. The bullish momentum of price and volume is obvious on the weeky chart with
the print of a massive bullish engulfing candle. Another earnings report is
due in 4 weeks. In the meanwhile, the news catalyst is VRTX and ALPN may be merging.
https://tradingview.sweetlogin.com/news/DJN_DN20240411006318:0/
I will take a risky long trade here with a stop loss at 50 and a profit first target
of 80 and the second at 90.
Note
The news catalyst is tradingview.com/news/DJN_DN20240411006318:0/Trade active
Gap higher on massive volume. 25% taken off due to risk of a reversal. Fanstastic trade so far including several call options over 100% overnight, One call optionclosed.maybe another tomorrow. All is good. Biotech on fire.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.